This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Shabeerali Pattasseri: Innovator in Pharmaceutical Formulations
Introduction
Shabeerali Pattasseri is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceutical formulations, particularly in enhancing the performance of amorphous solids and solubilized formulations. His work aims to achieve therapeutic plasma concentrations, which is crucial for effective medication delivery.
Latest Patents
Shabeerali holds 1 patent for his invention titled "Enhanced performance of amorphous solid and solubilized formulations for achieving therapeutic plasma concentrations." This invention focuses on solid amorphous Compound (I) and its formulations, which include solid amorphous dispersions and solution formulations. These formulations are designed to exhibit enhanced stability and bioavailability, making them valuable in therapeutic applications.
Career Highlights
Shabeerali is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role involves research and development in the area of drug formulations, where he applies his expertise to improve the efficacy of pharmaceutical products.
Collaborations
Shabeerali has worked alongside talented colleagues such as Jay Poorna Reddy and Theresa M Ziemba. Their collaborative efforts contribute to the innovative environment at Bristol-Myers Squibb, fostering advancements in drug formulation technologies.
Conclusion
Shabeerali Pattasseri's contributions to pharmaceutical formulations highlight the importance of innovation in achieving better therapeutic outcomes. His work continues to impact the field positively, paving the way for future advancements in medication delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
